Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 60601-2-57-11 (2016): Medical Electrical Equipment – Particular Requirements for Light-Based Diagnostic and Therapeutic Devices
Understanding the Canadian alignment with IEC 60601-2-57 for optical radiation safety and performance of electro-optical medical equipment
Introduction
CAN CSA C22.2 No. 60601-2-57-11 (2016) is the Canadian national adoption of IEC 60601-2-57:2011, a particular standard within the IEC 60601 series that specifies requirements for the basic safety and essential performance of medical electrical equipment emitting optical radiation for diagnostic or therapeutic purposes. This standard applies to devices such as surgical headlamps, endoscopic light sources, phototherapy units for neonatal jaundice, dental curing lights, and other electro-optical equipment used in direct contact or remote irradiation of the patient.
As a harmonized standard under the Canadian Medical Devices Regulations (SOR/98-282), compliance with CAN CSA C22.2 No. 60601-2-57-11 is often a prerequisite for obtaining a Medical Device License (MDL) from Health Canada. The standard incorporates the general requirements of CAN CSA C22.2 No. 60601-1 (the Canadian adoption of IEC 60601-1) and adds specialized provisions for optical radiation hazards, performance stability, and labelling.
Scope and Application
The standard covers all medical electrical equipment that intentionally delivers optical radiation with wavelengths between 200 nm and 3000 nm to the patient. This includes both incoherent (lamps, LEDs) and coherent (laser) sources, although laser products may also need to comply with CAN CSA C22.2 No. 60825-1 for additional laser safety requirements.
Specifically excluded from the scope are equipment intended for general illumination (e.g., operating room lamps that are not part of a therapeutic or diagnostic procedure), ophthalmic instruments covered by other particular standards, and equipment that applies optical radiation solely for thermal heating without a dedicated diagnostic or therapeutic function (e.g., infrared patient warmers).
The standard applies to equipment used by healthcare professionals in hospitals, clinics, and home care settings. For home-use devices, additional requirements from CAN CSA C22.2 No. 60601-1-11 (for home healthcare environment) may be invoked.
Technical Requirements
Optical Radiation Safety
The core of the standard is the limitation of optical radiation exposure to safe levels for patients, operators, and bystanders. The standard references the International Commission on Non-Ionizing Radiation Protection (ICNIRP) guidelines and IEC 62471 (Photobiological Safety of Lamps). Equipment must be classified into one of four risk groups (Exempt, Risk Group 1, 2, or 3) based on the accessible emission limits for retinal, corneal, and skin hazards relevant to the emitted spectrum.
| Risk Group | Hazard Description | Required Controls |
|---|---|---|
| Exempt | No photobiological hazard under normal conditions | None beyond basic labelling |
| RG1 (Low Risk) | Low risk; unlikely to cause harm under reasonable use | Warning label, user instructions |
| RG2 (Moderate Risk) | Potential hazard from very bright sources; aversion response may not be sufficient | Additional safety markings, shutter or intensity reduction for sustained exposure, operator training |
| RG3 (High Risk) | Hazardous even for momentary exposure | Interlocks, remote control, strict access control, audible/visible warnings, fail-safe design |
For devices intended for direct ocular exposure (e.g., diagnostic endoscopes), the standard imposes stricter limits on retinal blue-light hazard and thermal hazard to prevent photoretinopathy or corneal burns.
Performance Requirements
The standard mandates that the equipment achieve and maintain the specified output characteristics (irradiance, radiance, spectral distribution) within tolerances declared by the manufacturer. For therapeutic devices, such as phototherapy lamps for hyperbilirubinemia, the effective irradiance must be measured at the patient plane under standardized conditions. The standard also requires that the device deliver consistent output over its lifetime, especially for light sources with limited stability.
Key performance parameters that must be verified include:
- Spectral output and bandwidth (for devices using specific wavelengths, e.g., 450–475 nm for neonatal phototherapy)
- Beam profile and uniformity (for surgical headlamps and endoscopes)
- Pulse characteristics for pulsed sources (pulse energy, duration, repetition rate)
- Warm-up time and output stabilization
Marking and Documentation
In addition to the requirements of the general standard (CAN CSA C22.2 No. 60601-1), the particular standard requires specific markings on the equipment and in the accompanying documents:
- Risk group classification (e.g., “Risk Group 2 per CAN CSA C22.2 No. 60601-2-57-11”)
- Wavelength range and maximum accessible emission limits
- Statement of compliance with applicable optical radiation standards
- For high-risk devices (RG2 or RG3), additional warnings such as “Do not stare into the beam” or “Use only with provided shields”
Implementation Highlights
Manufacturers integrating CAN CSA C22.2 No. 60601-2-57-11 into their product development process should pay special attention to the following practical aspects:
When designing a new light source, conduct a preliminary risk assessment early using IEC 62471 to estimate the risk group. This allows you to plan the optical safety controls and avoid costly redesigns later. For devices targeting RG2 or RG3, consider adding a mechanical shutter or electronic dimming that activates after a preset exposure time to reduce risk.
Testing for Compliance
Compliance testing must be performed by an accredited laboratory that has the capability to measure optical radiation radiometrically and photometrically according to CIE standards. The test methods specified in Annex A of the standard provide guidance for measurement geometries, distances, and averaging times. Key testing considerations include:
- For all devices: determination of effective irradiance for blue light, thermal retinal hazard, and skin thermal hazard (depending on spectral content)
- For devices with interchangeable light guides or filters: verification that the combination complies with limits
- For pulsed sources: measurement of pulse energy and average power over representative duty cycles
Note that the standard requires that safety-critical components (e.g., filters, apertures, shielding) be either permanently fixed or interlocked to prevent removal by the user. Field-replaceable lamps must be designed so that only the manufacturer-specified lamp type can be installed and that the correct positioning is unambiguous.
Software and Alarms
If the device incorporates software to control output levels or to trigger alarms (e.g., over‑temperature, lamp failure), the software must comply with the requirements of IEC 62304 (Medical Device Software) as referenced via the collateral standard CAN CSA C22.2 No. 60601-1. Alarms for excessive exposure time must be distinct from general error signals and must be persistent until acknowledged.
Compliance and Certification Notes
For products intended for the Canadian market, compliance with CAN CSA C22.2 No. 60601-2-57-11 is typically demonstrated through a Type 1 or Type 2 certification audit by one of Canada’s recognized certification bodies (e.g., CSA Group, UL, TÜV SÜD). The standard is recognized by Health Canada as providing a presumption of conformity to relevant safety and performance requirements under the Medical Devices Regulations.
Meeting the requirements of CAN CSA C22.2 No. 60601-2-57-11 not only facilitates Health Canada licensing but also aligns the device with international best practices, as the core IEC 60601-2-57 is widely accepted in Europe, Australia, and many other jurisdictions. This helps streamline global market access.
National deviations specific to Canada may include stricter requirements for home‑use devices (additional marking in both English and French) and for devices intended for pediatric populations (where more conservative exposure limits may apply). Manufacturers should review the latest version of “CSA C22.2 No. 60601-2-57-11 – National Differences List” published by CSA Group.
Important: As of 2026, the 2016 edition remains current, but manufacturers should monitor for a planned revision to align with IEC 60601-2-57:2023, which introduces updated exposure limits based on the latest ICNIRP guidelines (2020) and new requirements for wearable and wireless‑controlled devices. Transition planning is strongly advised.
The standard also interacts with other CSA medical electrical standards. For example, combination products (e.g., a phototherapy lamp with integrated patient monitoring) must meet the applicable requirements of both the particular standard and the relevant collateral standards.
Frequently Asked Questions
Q: Does CAN CSA C22.2 No. 60601-2-57-11 apply to all light‑emitting medical devices?
A: No. It applies only to devices that intentionally deliver optical radiation for a diagnostic or therapeutic purpose. Devices that emit light solely for general illumination (e.g., ambient lighting in a surgery room) are not covered. Also, ophthalmic devices like slit lamps or fundus cameras are covered by other particular standards (e.g., CAN CSA C22.2 No. 60601-2-45). Laser‑based products may need dual compliance with 60825-1.
A: No. It applies only to devices that intentionally deliver optical radiation for a diagnostic or therapeutic purpose. Devices that emit light solely for general illumination (e.g., ambient lighting in a surgery room) are not covered. Also, ophthalmic devices like slit lamps or fundus cameras are covered by other particular standards (e.g., CAN CSA C22.2 No. 60601-2-45). Laser‑based products may need dual compliance with 60825-1.
Q: How is risk group classification determined?
A: The manufacturer must measure or compute the accessible emission limits (AELs) for each hazard (blue light, retinal thermal, skin thermal, UV, IR) according to the measurement methods in IEC 62471 and the annexes of the standard. The highest risk level among all hazard categories determines the overall risk group. Exempt and RG1 devices have fewer mandatory safety controls.
A: The manufacturer must measure or compute the accessible emission limits (AELs) for each hazard (blue light, retinal thermal, skin thermal, UV, IR) according to the measurement methods in IEC 62471 and the annexes of the standard. The highest risk level among all hazard categories determines the overall risk group. Exempt and RG1 devices have fewer mandatory safety controls.
Q: Can we use a certified IEC 60601-2-57 test report for Canadian certification?
A: Yes, provided the testing was performed by an accredited laboratory and the test report includes documentation of any differences between the IEC version and the CSA version (i.e., national deviations). The certification body will review the report for alignment with the Canadian standard. It is often more efficient to request a report that explicitly states compliance with CAN CSA C22.2 No. 60601-2-57-11.
A: Yes, provided the testing was performed by an accredited laboratory and the test report includes documentation of any differences between the IEC version and the CSA version (i.e., national deviations). The certification body will review the report for alignment with the Canadian standard. It is often more efficient to request a report that explicitly states compliance with CAN CSA C22.2 No. 60601-2-57-11.
Q: Are there special requirements for neonatal phototherapy devices?
A: Yes. Neonates have particularly sensitive skin and eyes. The standard’s annexes provide specific measurement conditions for phototherapy devices, including a standardized “baby” phantom and measurement at a distance typical for clinical use. The effective blue‑light irradiance must be measured and the device should be designed to minimize UV and IR output. Additionally, the device must include a mechanism to ensure the infant’s eyes are protected (e.g., use of eye patches) or the light source must be positioned to avoid direct eye exposure.
A: Yes. Neonates have particularly sensitive skin and eyes. The standard’s annexes provide specific measurement conditions for phototherapy devices, including a standardized “baby” phantom and measurement at a distance typical for clinical use. The effective blue‑light irradiance must be measured and the device should be designed to minimize UV and IR output. Additionally, the device must include a mechanism to ensure the infant’s eyes are protected (e.g., use of eye patches) or the light source must be positioned to avoid direct eye exposure.
Prepared with technical accuracy referencing the published edition of CAN CSA C22.2 No. 60601-2-57-11 (R2021). For the most current information, always consult the official CSA Group document and relevant Health Canada guidance.
Last updated: 2026